Filing Details
- Accession Number:
- 0001104659-22-036105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-21 16:06:00
- Reporting Period:
- 2022-03-18
- Accepted Time:
- 2022-03-21 16:06:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1173281 | Neubase Therapeutics Inc. | NBSE | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1765274 | P. Todd Branning | C/O 350 Technology Drive, Fourth Floor Pittsburgh PA 15219 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-18 | 10,000 | $1.81 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
